The Rocky Mountain MS Center’s 2018 Fall Education Summit is scheduled for Saturday, November 4 at the Anschutz Medical Campus in Aurora. Below is an archive of the entire event,…
Read More
Interview with Dr. Jeffrey Hebert, Associate Professor, Physical Medicine & Rehabilitation-Physical Therapy Program RMMSC: Could you please give us a brief overview of the PCORI study on MS and exercise? Dr….
By Becky Post, Certified Therapeutic Recreation Specialist, Adventure Recreation Coordinator at RMMSC’s King Adult Day Enrichment Program The RMMSC’s King Adult Day Enrichment Program (KADEP) offers several outing opportunities for…
The development of new treatments in MS has exploded. Currently there are at least 15 disease modifying agents available with more anticipated to be approved in the next few years….
This week, the results from a clinical trial of 250 participants with progressive MS were released and showed that ibudilast on had a significant impact in slowing down brain volume…
This past month, the MSYPN met with RMMSC Board Chair, Del Arnold, and Board Member, Erica Tarpey. Del and Erica discussed their careers, what led them to the RMMSC board, and…
Medical appointments tend to be too short to address all our concerns and care does not always feel patient-centered. In an effort to reme-dy these common experiences and give patients…
An Interview with Dr. Roger Enoka with the Neurophysiology of Movement Laboratory at University of Colorado Boulder campus Dr. Roger Enoka, a professor at the University of Colorado Boulder, has…
Quite a bit’s going on in the world of disease modifying therapies (DMTs), and we’ve prepared a brief update for you. Read on for more about Gilenya’s FDA approval for…
The Rocky Mountain MS Center hosted the 2018 Spring Education Summit in Aurora on Saturday, May 12. We’ve archived the main content of the Summit to share with everyone that…